http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.
Weinhold, N. ; Kirn, D. ; Seckinger, A. ; Hielscher, T.DKFZ* ; Granzow, M. ; Bertsch, U. ; Egerer, G. ; Salwender, H. ; Blau, I. W. ; Weisel, K. ; Hillengass, J.DKFZ* ; Raab, M.-S.DKFZ* ; Hose, D. ; Goldschmidt, H.DKFZ* ; Jauch, A.
2016
Ferrata Storti Foundation
Pavia
This record in other databases:

Please use a persistent id in citations: doi:10.3324/haematol.2015.136929
Keyword(s): Antineoplastic Agents ; MYC protein, human ; Proto-Oncogene Proteins c-myc
Contributing Institute(s):
- Biostatistik (C060)
- Radiologie (E010)
- Experimentelle Therapien hämatologischer Neoplasien (G170)
- KKE Molekulare Hämatologie/Onkologie (G330)
- NCT-KliHD (V964)
Research Program(s):
- 317 - Translational cancer research (POF3-317) (POF3-317)
Appears in the scientific report
2016
Database coverage:
;

;

; BIOSIS Previews ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DOAJ Seal ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection